Oh I - Search Results

1

Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.

Noborio-Hatano K, Kikuchi J, Takatoku M, Shimizu R, Wada T, Ueda M, Nobuyoshi M, Oh I, Sato K, Suzuki T, Ozaki K, Mori M, Nagai T, Muroi K, Kano Y, Furukawa Y, Ozawa K. Noborio-Hatano K, et al. Among authors: oh i. Oncogene. 2009 Jan 15;28(2):231-42. doi: 10.1038/onc.2008.385. Epub 2008 Oct 13. Oncogene. 2009. PMID: 18850009

2

Pleocytosis after hemopoietic stem cell transplantation.

Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Tatara R, Meguro A, Fujiwara S, Obara Y, Oh I, Kikuchi S, Sato K, Matsuyama T, Toshima M, Ohmine K, Ozaki K, Takatoku M, Mori M, Nagai T, Ozawa K. Nagashima T, et al. Among authors: oh i. Leuk Lymphoma. 2006 Aug;47(8):1613-7. doi: 10.1080/10428190600625836. Leuk Lymphoma. 2006. PMID: 16966274

3

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K. Sato K, et al. Among authors: oh i. Blood. 2007 Jan 1;109(1):228-34. doi: 10.1182/blood-2006-02-002246. Epub 2006 Sep 19. Blood. 2007. PMID: 16985180 Free article.

4

Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells.

Oh I, Ozaki K, Sato K, Meguro A, Tatara R, Hatanaka K, Nagai T, Muroi K, Ozawa K. Oh I, et al. Biochem Biophys Res Commun. 2007 Apr 20;355(4):956-62. doi: 10.1016/j.bbrc.2007.02.054. Epub 2007 Feb 21. Biochem Biophys Res Commun. 2007. PMID: 17336935

5

Screening of genes responsible for differentiation of mouse mesenchymal stromal cells by DNA micro-array analysis of C3H10T1/2 and C3H10T1/2-derived cell lines.

Oh I, Ozaki M, Miyazato A, Sato K, Meguro A, Muroi K, Nagai T, Mano H, Ozawa K. Oh I, et al. Cytotherapy. 2007;9(1):80-90. doi: 10.1080/14653240601016374. Cytotherapy. 2007. PMID: 17361490

6

Mechanisms of immunomodulation by mesenchymal stem cells.

Ozaki K, Sato K, Oh I, Meguro A, Tatara R, Muroi K, Ozawa K. Ozaki K, et al. Among authors: oh i. Int J Hematol. 2007 Jul;86(1):5-7. doi: 10.1532/IJH97.07003. Int J Hematol. 2007. PMID: 17675259 Review.

7

Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy.

Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Ono Y, Kikuchi S, Sato K, Ueda M, Toshima M, Ozaki K, Takatoku M, Nagai T, Ozawa K. Oka S, et al. Among authors: oh i. Intern Med. 2007;46(19):1669-70. doi: 10.2169/internalmedicine.46.0345. Epub 2007 Oct 1. Intern Med. 2007. PMID: 17917331 Free article. No abstract available.

8

Cell and gene therapy using mesenchymal stem cells (MSCs).

Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A. Ozawa K, et al. Among authors: oh i. J Autoimmun. 2008 May;30(3):121-7. doi: 10.1016/j.jaut.2007.12.008. Epub 2008 Jan 31. J Autoimmun. 2008. PMID: 18249090 Review.

9

Prediction of response to imatinib in patients with chronic myelogenous leukemia by flow cytometric analysis of bone marrow blastic cell phenotypes.

Oka S, Muroi K, Mori M, Matsuyama T, Fujiwara S, Oh I, Sato K, Kikuchi S, Ueda M, Toshima M, Suzuki T, Ozaki K, Nagai T, Ozawa K. Oka S, et al. Among authors: oh i. Leuk Lymphoma. 2009 Feb;50(2):290-3. doi: 10.1080/10428190802627598. Leuk Lymphoma. 2009. PMID: 19197727 No abstract available.

10

IL-21 is critical for GVHD in a mouse model.

Meguro A, Ozaki K, Oh I, Hatanaka K, Matsu H, Tatara R, Sato K, Leonard WJ, Ozawa K. Meguro A, et al. Among authors: oh i. Bone Marrow Transplant. 2010 Apr;45(4):723-9. doi: 10.1038/bmt.2009.223. Epub 2009 Aug 31. Bone Marrow Transplant. 2010. PMID: 19718060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,482 results

Search Page